Image Source: Unsplash – Pharmaceuticals in Packages
Understanding HSA Compliance: A Practical Guide for Medical Importers in Singapore
For healthcare companies eyeing expansion into Southeast Asia, Singapore is a key launchpad. But entering the market isn’t just about having a great product — it’s about meeting the country’s strict regulatory standards. That’s where HSA compliance comes in.
Whether you’re importing diagnostic kits, medical equipment, or pharmaceuticals, this guide will walk you through what you need to know to comply with Singapore’s regulatory framework.
What Is HSA and Why Is It Crucial for Health Products in Singapore?
The Health Sciences Authority (HSA) is Singapore’s regulatory authority overseeing medical devices and therapeutic products, ensuring they meet strict standards of safety, effectiveness, and quality. From basic diagnostic tools to complex implantable devices, HSA regulates all medical devices using a structured system that classifies them by risk level.
Singapore’s Ministry of Health reinforces strict medical product governance, working closely with HSA to regulate the import, distribution, and registration of medical devices and therapeutic products. This ensures all health products entering the Singapore market meet both clinical and safety benchmarks (MOH, 2024).
Not adhering to regulations can lead to serious repercussions such as confiscated shipments, fines, delayed market entry, or product recalls. Only products that meet HSA’s requirements may be supplied in Singapore’s healthcare market (HSA, 2026), making HSA compliance in Singapore a critical consideration from day one.
Who Needs to Register Their Products with the HSA?
If you’re introducing a medical product into Singapore — even if it’s already registered overseas — it likely needs HSA clearance. This applies to:
- Local distributors bringing in products from abroad
- Overseas companies looking to sell in Singapore
- Startups launching new health tech or innovations
Don’t have a local office? You’ll need to appoint a Singapore-based Authorized Representative (AR). They’ll handle application submissions and be your point of contact with the HSA. According to legal insights shared by Lexology, appointing a local AR is a mandatory step for all foreign medical companies entering the Singapore market (Tan & Wong, 2025).
PRISM and SHARE: Your Regulatory Companion Step-by-Step – Using the PRISM and SHARE Systems
PRISM (Pharmaceutical Regulatory Information System) and SHARE (Singapore Health Product Access and Regulatory E-System) are the Health Sciences Authority’s online portals used for registering and managing health product applications in Singapore. They are the official gateway for submitting medical device and therapeutic product registrations, product dossiers, and filing of post-market changes.
Below is a step-by-step overview to help registrants use the systems effectively.
- Account Creation: Before anything else, companies must register for a CorpPass account and apply for a new CRIS account. This allows the company’s appointed CRIS user accounts to transact online with HSA.
- Determine Product Type: There are multiple health product categories, including therapeutic products and medical devices, . Determine the appropriate category before starting an application. SHARE can be used for applications regarding medical device and cell, tissue or gene therapy products. PRISM can be used for applications regarding all other health products eg. Therapeutic products, poisons, controlled drugs.
- Classify the Medical Device or Product: Use HSA’s online risk classification tool or guidance documents to determine the classification of your product (see below).
- Submit Application: Fill in the online form on the system, attach necessary documentation and pay the relevant fee.
- Track and Respond: SHARE and PRISM allow applicants to track the application status. If HSA requests additional information, it must be uploaded within a specific timeframe.
- Receive Approval: Once approved, the product will be listed in HSA’s registries and can legally be imported and distributed in Singapore by the authorised importers.
Ensuring a complete and accurate submission from the start helps prevent unnecessary delays. The most common issues are incorrect classification and missing documentation. Partnering with a local regulatory expert experienced with the requirements can reduce these risks.
Understanding Risk Classifications of Medical Devices (Class A–D)
HSA classifies medical devices into four categories based on risk to patients and users:
- Class A (Low Risk): Non-invasive products like wheelchairs or tongue depressors. These are exempt from registration, though listing is still required.
- Class B (Low-Moderate Risk): Devices like suction equipment or hypodermic needles. Requires submission with basic safety and performance data.
- Class C (Moderate-High Risk): Products like bone fixation plates or ventilators. These need more in-depth clinical evaluation and manufacturing documentation.
- Class D (High Risk): Devices that sustain or support life, such as pacemakers, heart valves, or implantable defibrillators. These require extensive clinical evidence, technical documentation, and often third-party conformity assessments.
If you’re unsure where your product fits, consult HSA’s guidance or work with a local expert.
What Documents Are Typically Required?
While requirements vary by classification, HSA generally expects:
- Letters of authorisation
- Executive summary
- Device description
- Technical documentation such as Design verification and validation documents
- Clinical evidence
- Labelling and instructions for use
- Manufacturer Information
- Proof of manufacturing sites’ quality management system
Preparing these documents according to HSA guidelines is a key part of regulatory support, especially for SMEs that do not have in-house regulatory specialists (HSA, 2026).
Common Pitfalls Medical Importers Face
Even experienced businesses make mistakes that slow down approvals. Here are the common ones:
- Wrong Classification: Submitting under the wrong class is one of the biggest delays.
- Missing Documentation: Incomplete technical files or unclear labelling lead to follow-ups.
- No Local AR: HSA won’t accept direct submissions from foreign companies.
- Unrealistic Timelines: Depending on the product class, approvals can range from immediate to months to years.
These errors often lead to delays that affect product launch timelines and revenue.
How Local Regulatory Partners Simplify the Process
Navigating regulations isn’t just about ticking boxes. A reliable partner with HSA experience can help:
- Clarify product classification
- Review documents before submission
- Handle communication with the HSA
- Support post-market responsibilities (like change notification submissions)
The right support gives you peace of mind — and helps you avoid the trial and error that often slows down market entry.
Labgistics Asia helps healthcare companies simplify product registration in Singapore and reduce regulatory risks through end-to-end compliance support. Learn more about our Regulatory Services
Frequently Asked Questions
Q: How long does it take to receive HSA approval in Singapore?
A: The review timeline depends on the product’s risk classification. Low-risk Class A products do not require registration approval and may be imported and supplied in Singapore after listing on class A database, while higher-risk Class B, C and D items can take several months to years due to the depth of review required by Singapore’s Health Sciences Authority (HSA).
Q: Is HSA registration required for all healthcare products sold in Singapore?
A: Not all products require full registration. For example, many low-risk Class A medical devices only need to be listed with the HSA, while Class B to D products typically go through the complete registration evaluation process before they can be distributed in Singapore.
Q: Can an overseas company submit an HSA application directly?
A: No. If your company isn’t registered in Singapore, you must appoint a local Authorized Representative (AR). The AR is responsible for submitting applications through HSA’s SHARE and PRISM systems and handling post-approval regulatory correspondence.
Q: Does HSA product approval in Singapore last indefinitely?
A: No. Product registrations are valid for a fixed period and require renewal before expiry, although this renewal is an automated process. In addition, companies must comply with Singapore’s post-market surveillance guidelines, including recalls, adverse event reporting, and product updates.
Q: What is the timeline for HSA approval?
A: Timelines vary based on device classification and submission completeness, ranging from immediate to several months or years.
References
Health Sciences Authority. (2026). Medical devices regulatory overview. https://www.hsa.gov.sg/medical-devices/regulatory-overview
Ministry of Health Singapore. (2024). Health products and medical device regulation. https://www.moh.gov.sg/others/health-regulation/health-products-and-medical-device-regulation
Tan, Y. L., & Wong, J. Y. (2025). Navigating regulatory approval in Singapore. Lexology. https://www.lexology.com/library/detail.aspx?g=d0685ed4-fe12-4f78-89a6-3eb8b9d00852